Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GE HEALTHCARE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   2.9% 6.2% 5.5% 6.3% 2.4% 2.5% 8.0% 8.0%   Credit score (0-100)   60 39 41 36 63 61 31 31   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   12,122 12,342 10,646 9,427 9,033 9,360 0.0 0.0   EBITDA   1,864 1,671 2,103 1,663 1,651 1,468 0.0 0.0   EBIT   1,864 1,671 2,103 1,663 1,651 1,468 0.0 0.0   Pre-tax profit (PTP)   1,589.4 1,506.2 1,970.5 1,621.7 1,730.7 1,800.0 0.0 0.0   Net earnings   1,294.9 1,094.9 1,531.9 1,257.5 1,342.3 1,389.9 0.0 0.0   Pre-tax profit without non-rec. items   1,589 1,506 1,971 1,622 1,731 1,800 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   39,475 40,570 42,102 46,622 12,964 14,354 11,554 11,554   Interest-bearing liabilities   15,657 12,643 5,943 3,328 4,522 11,471 0.0 0.0   Balance sheet total (assets)   58,616 56,873 52,361 54,470 22,057 30,791 11,554 11,554   Net Debt   15,657 12,643 5,943 3,328 4,522 11,471 -11,554 -11,554     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   12,122 12,342 10,646 9,427 9,033 9,360 0.0 0.0   Gross profit growth   -11.5% 1.8% -13.7% -11.5% -4.2% 3.6% -100.0% 0.0%   Employees   4 4 3 3 3 3 0 0   Employee growth %   -20.0% 0.0% -25.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   58,616 56,873 52,361 54,470 22,057 30,791 11,554 11,554   Balance sheet change%   6.1% -3.0% -7.9% 4.0% -59.5% 39.6% -62.5% 0.0%   Added value   1,864.0 1,671.4 2,103.4 1,663.0 1,651.5 1,468.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.4% 13.5% 19.8% 17.6% 18.3% 15.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.3% 2.9% 3.9% 3.1% 4.5% 7.2% 0.0% 0.0%   ROI %   3.5% 3.1% 4.2% 3.4% 5.1% 8.8% 0.0% 0.0%   ROE %   3.3% 2.7% 3.7% 2.8% 4.5% 10.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   67.3% 71.3% 80.4% 85.6% 58.8% 46.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   840.0% 756.4% 282.5% 200.1% 273.8% 781.3% 0.0% 0.0%   Gearing %   39.7% 31.2% 14.1% 7.1% 34.9% 79.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.8% 1.2% 1.4% 0.9% 0.0% 1.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.8 3.2 4.8 6.5 2.3 1.6 0.0 0.0   Current Ratio   3.1 3.5 5.1 6.9 2.4 1.9 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   39,474.7 40,569.6 42,101.5 46,622.0 12,964.4 14,354.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   466 418 701 554 550 489 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   466 418 701 554 550 489 0 0   EBIT / employee   466 418 701 554 550 489 0 0   Net earnings / employee   324 274 511 419 447 463 0 0